Geneviewe Napper - Publications

Affiliations: 
1990-1992 Optometry  University of Melbourne, Parkville, Victoria, Australia 

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Napper G, Fricke T, Anjou MD, Jackson AJ. Breaking down barriers to eye care for Indigenous people: a new scheme for delivery of eye care in Victoria. Clinical & Experimental Optometry. 98: 430-4. PMID 26390905 DOI: 10.1111/cxo.12325  0.68
2014 Truong M, Bentley SA, Napper GA, Guest DJ, Anjou MD. How Australian and New Zealand schools of optometry prepare students for culturally competent practice. Clinical & Experimental Optometry. 97: 540-9. PMID 25138959 DOI: 10.1111/cxo.12196  0.68
2013 Napper GA, Sorraghan J, Wood J, Crerie G, Morse A. Re: Why optometry must work from urban and regional Aboriginal Health Services. Clinical & Experimental Optometry. 96: 249-50. PMID 23496657 DOI: 10.1111/cxo.12041  0.68
2012 Napper GA, Truong M, Anjou MD. There are people in Australia who have poor vision or eye disease that is avoidable. What more can we do? Clinical & Experimental Optometry. 95: 569-71. PMID 23106402 DOI: 10.1111/j.1444-0938.2012.00790.x  0.68
2009 Kiely PM, Lian KY, Napper G, Lakkis C. Influenza A(H1N1) and infection control guidelines for optometrists. Clinical & Experimental Optometry. 92: 490-4. PMID 19758421 DOI: 10.1111/j.1444-0938.2009.00420.x  0.68
2007 Lakkis C, Lian KY, Napper G, Kiely PM. Infection control guidelines for optometrists 2007. Clinical & Experimental Optometry. 90: 434-44. PMID 17958566 DOI: 10.1111/j.1444-0938.2007.00192.x  0.68
2007 Albietz J, Douglas I, Napper G. Ocular therapeutics. Clinical & Experimental Optometry. 90: 303. PMID 17535371 DOI: 10.1111/j.1444-0938.2007.00165.x  0.68
2007 Albietz J, Douglas I, Napper G. Ocular therapeutics. Clinical & Experimental Optometry. 90: 141-2. PMID 17311577 DOI: 10.1111/j.1444-0938.2007.00126.x  0.68
2006 Napper G, Douglas I, Albietz J. Ocular therapeutics. Clinical & Experimental Optometry. 89: 396-7. PMID 17026611 DOI: 10.1111/j.1444-0938.2006.00095.x  0.68
2006 Napper G, Douglas I, Albietz J. Optometry ocular therapeutics Clinical and Experimental Optometry. 89: 334-335. DOI: 10.1111/j.1444-0938.2006.00078.x  0.68
2005 Wolffsohn JS, Eperjesi F, Napper G. Evaluation of Melbourne Edge Test contrast sensitivity measures in the visually impaired. Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists). 25: 371-4. PMID 15953123 DOI: 10.1111/j.1475-1313.2005.00282.x  0.68
2004 Eperjesi F, Wolffsohn J, Bowden J, Napper G, Rubinstein M. Normative contrast sensitivity values for the back-lit Melbourne Edge Test and the effect of visual impairment. Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists). 24: 600-6. PMID 15491489 DOI: 10.1111/j.1475-1313.2004.00248.x  0.68
2004 Albietz J, Douglas I, Napper G. Ocular therapeutics. Clinical & Experimental Optometry. 87: 124-5. PMID 15106590 DOI: 10.1111/j.1444-0938.2004.tb03160.x  0.68
2003 Napper G, Douglass I, Albietz J. Preservative and antibiotic toxicity to the ocular surface. Clinical & Experimental Optometry. 86: 414-5. PMID 14702947  0.68
2003 Napper G, Albeitz J, Douglas I. Scheduling of controlled substances in Australia and New Zealand. Clinical & Experimental Optometry. 86: 63-4. PMID 12602332  0.68
2003 Napper G, Douglas I, Albietz J. Optometry: Ocular therapeutics Clinical and Experimental Optometry. 86: 350-351. DOI: 10.1111/j.1444-0938.2003.tb03132.x  0.68
2002 Kalloniatis M, Napper GA. Retinal neurochemical changes following application of glutamate as a metablolic substrate. Clinical & Experimental Optometry : Journal of the Australian Optometrical Association. 85: 27-36. PMID 11952393 DOI: 10.1111/j.1444-0938.2002.tb03069.x  0.68
2002 Kalloniatis M, Napper GA. Retinal neurochemical changes following application of glutamate as a metabolic substrate Clinical and Experimental Optometry. 85: 27-36. DOI: 10.1111/j.1444-0938.2002.tb03069.x  0.52
2001 Wolffsohn JS, Napper GA, Ho SM, Jaworski A, Pollard TL. Improving the description of the retinal vasculature and patient history taking for monitoring systemic hypertension. Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists). 21: 441-9. PMID 11727872 DOI: 10.1016/S0275-5408(01)00021-7  0.68
2001 Hurcomb PG, Wolffsohn JS, Napper GA. Ocular signs of systemic hypertension: a review. Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists). 21: 430-40. PMID 11727871 DOI: 10.1016/S0275-5408(01)00022-9  0.68
2001 Napper GA, Pianta MJ, Kalloniatis M. Localization of amino acid neurotransmitters following in vitro ischemia and anoxia in the rat retina. Visual Neuroscience. 18: 413-27. PMID 11497418 DOI: 10.1017/S0952523801183082  0.68
2000 Jaworski A, Wolffsohn JS, Napper GA. Detection, aetiology and management of conjunctival intraepithelial neoplasia. Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists). 20: 371-80. PMID 11045245  0.68
1999 Napper GA, Kalloniatis M. Neurochemical changes following postmortem ischemia in the rat retina. Visual Neuroscience. 16: 1169-80. PMID 10614596 DOI: 10.1017/S0952523899166161  0.68
1999 Napper GA, Pianta MJ, Kalloniatis M. Reduced glutamate uptake by retinal glial cells under ischemic/hypoxic conditions. Visual Neuroscience. 16: 149-58. PMID 10022486 DOI: 10.1017/S0952523899161108  0.68
1997 Napper GA, Brennan NA, Barrington M, Squires MA, Vessey GA, Vingrys AJ. The effect of an interrupted daily period of normal visual stimulation on form deprivation myopia in chicks. Vision Research. 37: 1557-64. PMID 9231222 DOI: 10.1016/S0042-6989(96)00269-6  0.68
1996 Kalloniatis M, Napper GA. Glutamate metabolic pathways in displaced ganglion cells of the chicken retina. The Journal of Comparative Neurology. 367: 518-36. PMID 8731223 DOI: 10.1002/(SICI)1096-9861(19960415)367:4<518::AID-CNE4>3.0.CO;2-7  0.68
1995 Napper GA, Brennan NA, Barrington M, Squires MA, Vessey GA, Vingrys AJ. The duration of normal visual exposure necessary to prevent form deprivation myopia in chicks. Vision Research. 35: 1337-44. PMID 7610595 DOI: 10.1016/0042-6989(94)00226-C  0.68
Show low-probability matches.